Incidence of Atrioventricular Block After Valve Replacement in Carcinoid Heart Disease

Igor Sunjic1,2, Doosup Shin3,2, Katlynd M Sunjic4

  • 1Division of Cardiovascular Sciences, University of South Florida Morsani College of Medicine, Tampa, FL 33606, USA.

Cardiology Research
|February 26, 2020
PubMed

Insights

Carcinoid heart disease patients undergoing valve surgery have a high risk of atrioventricular block (AVB). Nearly one-third required pacemaker implantation, suggesting prophylactic lead placement may be beneficial.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Oncology

Background:

  • Carcinoid heart disease (CaHD) significantly impacts patient morbidity and mortality.
  • Cardiac valve surgery is the primary treatment for heart failure in CaHD.
  • Atrioventricular block (AVB) is a known complication, but its incidence in CaHD is understudied.

Purpose of the Study:

  • To determine the incidence of AVB after valve surgery in CaHD patients.
  • To evaluate the need for permanent pacemaker (PPM) implantation post-surgery.
  • To inform potential prophylactic strategies.

Main Methods:

  • Retrospective analysis of consecutive CaHD patients undergoing valve surgery (2001-2015).
  • Exclusion of patients with pre-existing permanent pacemakers (PPM).
  • Data collection on baseline characteristics, ECG, and echocardiography.

Main Results:

  • Nineteen patients included; 18 had dual valve replacement.
  • Zero 30-day post-surgical mortality.
  • 31.5% (n=6) required PPM implantation for complete AVB within 6 months.
  • No significant differences in baseline parameters between PPM and non-PPM groups.

Conclusions:

  • Approximately one-third of CaHD patients require PPM after valve replacement due to AVB.
  • Prophylactic epicardial lead placement during surgery may prevent complications.
  • This strategy could reduce risks associated with later pacemaker lead insertion.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
302
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
275
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
313
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
386
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
10.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
684